Fungal infections have become a problem of increasing importance over the past last decades, especially in patients with immunological impairment, due to HIV infections, organ transplantations or cancer therapy. The most frequently diagnosed fungal infections are caused by pathogens of the genera Candida, Cryptococcus and Aspergillus. Current treatments use a limited number of antifungal drugs and the increased resistance to these molecules is now a great problem in medicine. Is then important to select and develop new antifungal therapeutics. Thiosemicarbazones have received great interest because of their chemical and biological activities, such as antibacterial, antivirus, antiamoebic, and antitumor activities in human pharmacology. In order to test if an antifungal activity is associated to some of these molecules we screened 16 different thiosemicarbazone molecules, against a panel of fungal pathogens. Two of these compounds showed interesting activity. Results will be here presented.

Screening of thiosemicarbazones as antimycotic drugs / Nolli, C.; Giovati, L.; Ciociola, T.; Bisceglie, F.; Pelosi, G.; Buschini, A.; Magliani, V.; Lodi, T.. - (2014), pp. 60-60. ((Intervento presentato al convegno XIII FISV Congress tenutosi a Pisa nel 24-27 settembre 2014.

Screening of thiosemicarbazones as antimycotic drugs

NOLLI, Cecilia;GIOVATI, Laura;CIOCIOLA, Tecla;BISCEGLIE, Franco;PELOSI, Giorgio;BUSCHINI, Annamaria;MAGLIANI, Valter;LODI, Tiziana
2014

Abstract

Fungal infections have become a problem of increasing importance over the past last decades, especially in patients with immunological impairment, due to HIV infections, organ transplantations or cancer therapy. The most frequently diagnosed fungal infections are caused by pathogens of the genera Candida, Cryptococcus and Aspergillus. Current treatments use a limited number of antifungal drugs and the increased resistance to these molecules is now a great problem in medicine. Is then important to select and develop new antifungal therapeutics. Thiosemicarbazones have received great interest because of their chemical and biological activities, such as antibacterial, antivirus, antiamoebic, and antitumor activities in human pharmacology. In order to test if an antifungal activity is associated to some of these molecules we screened 16 different thiosemicarbazone molecules, against a panel of fungal pathogens. Two of these compounds showed interesting activity. Results will be here presented.
Screening of thiosemicarbazones as antimycotic drugs / Nolli, C.; Giovati, L.; Ciociola, T.; Bisceglie, F.; Pelosi, G.; Buschini, A.; Magliani, V.; Lodi, T.. - (2014), pp. 60-60. ((Intervento presentato al convegno XIII FISV Congress tenutosi a Pisa nel 24-27 settembre 2014.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11381/2785299
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact